J. Schetz

发表

Pharmacology of the high-affinity apamin receptor in rabbit heart.

J. Schetz, P. Anderson, 1995, Cardiovascular research.

Structure-Activity Relationships: Theory, Uses and Limitations

J. Schetz, 2014 .

An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones.

J. Schetz, Ivan Lee, Shiuhwei Chen, 2008, European journal of pharmacology.

Brain-derived neurotrophic factor for high-throughput evaluation of selective Sigma-1 receptor ligands.

Dhwanil A. Dalwadi, D. Schreihofer, J. Schetz, 2021, Journal of pharmacological and toxicological methods.

New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea.

A. D. Buss, K. Ang, M. Hamann, 2002, Journal of natural products.

Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia

Dhwanil A. Dalwadi, J. Schetz, Seongcheol Kim, 2017, Neurochemistry International.

Detection and characterization of a B cell stimulatory factor (BSF-TC) derived from a bone marrow stromal cell line.

P. Isakson, K. Lynch, J. Schetz, 1989, Journal of immunology.

Pharmacotherapeutic Principles of Neurological and Psychiatric Disorders

J. Schetz, 2005 .

Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.

D. Sibley, A. Chu, J. Schetz, 1999, The Journal of pharmacology and experimental therapeutics.

Evidence that ‘Activated’ Prothrombin Concentrates Enhance Platelet Coagulant Activity

M. Verstraete, J. Vermylen, J. Schetz, 1978, British journal of haematology.

Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration

M. Verstraete, D. Collen, J. Schetz, 1977, European journal of clinical investigation.

The binding-site crevice of the D4 dopamine receptor is coupled to three distinct sites of allosteric modulation.

D. Sibley, J. Schetz, 2001, The Journal of pharmacology and experimental therapeutics.

Cannabinoids inhibit zebra mussel (Dreissena polymorpha) byssal attachment: a potentially green antifouling technology

J. Schetz, R. F. Mcmahon, M. Angarano, 2009, Biofouling.

Exploration of structure-antifouling relationships of capsaicin-like compounds that inhibit zebra mussel (Dreissena polymorpha) macrofouling

J. Schetz, R. F. Mcmahon, D. L. Hawkins, 2007, Biofouling.

Transmembrane Segment Five Serines of the D4 Dopamine Receptor Uniquely Influence the Interactions of Dopamine, Norepinephrine, and Ro10-4548

Spencer S. Ericksen, J. Schetz, D. Cummings, 2010, Journal of Pharmacology and Experimental Therapeutics.

Microsoft Word-71781792-file00

Spencer S. Ericksen, J. Schetz, D. Cummings, 2010 .

A prototypical Sigma-1 receptor antagonist protects against brain ischemia

J. Simpkins, Ran Liu, E. Perez, 2007, Brain Research.

Allosteric modulation of dopamine receptors.

J. Schetz, 2005, Mini reviews in medicinal chemistry.

Biochemical Changes Noted during Intermittent Administration of Streptokinase

M. Verstraete, J. Vermylen, J. Schetz, 1978, Thrombosis and Haemostasis.

INVESTIGATIONS OF LIPID COMPONENTS OF NEURONE-ENRICHED MEMBRANES OF THE JELLYFISH CYANEA CAPILLATA

J. Schetz, P. Anderson, 1993 .

Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: Measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation

Harel Weinstein, John A. Schetz, Zeynep H. Gümüş, 2009, Neuropharmacology.

FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia

J. Feldon, Weining Zhang, F. Boeckler, 2004, Psychopharmacology.

Synthesis and structure-affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypes.

James E. Johnson, Diana C. Canseco, J. Schetz, 2010, Bioorganic & medicinal chemistry.

Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.

Dhwanil A. Dalwadi, J. Schetz, Seongcheol Kim, 2016, Pharmacological research.

Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats.

C. M. Bertha, F. Porreca, J. Schetz, 1996, The Journal of pharmacology and experimental therapeutics.

Interferon therapy in multiple myeloma: failure of human fibroblast interferon administration to the course of light chain disease.

G. Tricot, R. Verwilghen, A. Billiau, 1981, European journal of cancer & clinical oncology.

Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs

Dhwanil A. Dalwadi, B. Harvey, J. Schetz, 2018, Pharmacological Reviews.

The HIV Antiretroviral Drug Efavirenz has LSD-Like Properties

Javier González-Maeso, A. Kozlenkov, J. González-Maeso, 2013, Neuropsychopharmacology.

The dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites

J. Schetz, G. Dillon, Zhenglan Chen, 2017, Neuropharmacology.

Clinical trial of Brinase and anticoagulants as a method of treatment for advanced limb ischemia

M. Verstraete, J. Vermylen, R. Verhaeghe, 2004, European Journal of Clinical Pharmacology.

Pattern recognition metric for comparison of protein structures based on amino acid sequences.

J A Schetz, J. Schetz, 1994, Methods in enzymology.

Protein Expression in the Drosophila Schneider 2 Cell System

E. Shankar, J. Schetz, 2004, Current protocols in neuroscience.

Pharmacological Characterization of Mammalian D1 and D2 Dopamine Receptors Expressed in Drosophila Schneider‐2 Cells

D. Sibley, J. Schetz, Ok‐Jin Kim, 2003, Journal of receptor and signal transduction research.

In Vitro and In Vivo Evaluation of N‐{2‐[4‐(3‐Cyanopyridin‐2‐yl)piperazin‐1‐yl]ethyl}‐3‐[11C]methoxybenzamide, a Positron Emission Tomography (PET) Radioligand for Dopamine D4 Receptors, in Rodents

S. Ametamey, E. Lacivita, M. Leopoldo, 2014, Chemistry & biodiversity.

Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes

David R. Sibley, John A. Schetz, R. Mailman, 1999, Neuropsychopharmacology.

Synthesis and Characterization of Aplysinopsin Analogs

James E. Johnson, Diana C. Canseco, F. Fronczek, 2009 .

Dopamine D2‐Receptor Isoforms Expressed in AtT20 Cells Inhibit Q‐Type High‐Voltage‐Activated Ca2+ Channels via a Membrane‐Delimited Pathway

B. Chronwall, S. Morris, R. Webber, 1999, Journal of neurochemistry.

Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity

Spencer S Ericksen, Spencer S. Ericksen, J. Schetz, 2009, Journal of neurochemistry.

Dopamine Receptor Microdomains Involved in Molecular Recognition and the Regulation of Drug Affinity and Function

Christina Z Floresca, J. Schetz, Christina Z. Floresca, 2004, Journal of receptor and signal transduction research.

Certain 1,4-Disubstituted Aromatic Piperidines and Piperazines with Extreme Selectivity for the Dopamine D4 Receptor Interact with a Common Receptor Microdomain

Peter Gmeiner, Sandhya Kortagere, Harel Weinstein, 2004, Molecular Pharmacology.

Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.

D. Sibley, J. Schetz, P. Benjamin, 2000, Molecular pharmacology.

Zinc Allosterically Modulates Antagonist Binding to Cloned D1 and D2 Dopamine Receptors

D. Sibley, J. Schetz, 1997, Journal of neurochemistry.

Protein Expression in the Drosophila Schneider 2 Cell System

J. Schetz, 1999 .

Ligand Selectivity of D2 Dopamine Receptors Is Modulated by Changes in Local Dynamics Produced by Sodium Binding

Harel Weinstein, Spencer S Ericksen, Spencer S. Ericksen, 2009, Journal of Pharmacology and Experimental Therapeutics.

Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine

P. Voulalas, J. Schetz, Pamela J. Voulalas, 2011, Molecular and Cellular Neuroscience.

Glycosylation patterns of membrane proteins of the jellyfish Cyanea capillata

J. Schetz, P. Anderson, 1995, Cell and Tissue Research.

Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.

T. Suhara, E. Lacivita, M. Leopoldo, 2010, Journal of medicinal chemistry.

Neurological and Psychiatric Disorders

F. Tarazi, J. Schetz, 2005 .

Adenosine receptor mediates motility in human melanoma cells.

L. Liotta, D. Amanatullah, E. Woodhouse, 1998, Biochemical and biophysical research communications.

Comparative Exploration of the Structure–Activity Space of Cloned α-Like Octopamine Receptors from a Marine and a Terrestrial Arthropod

Dhwanil A. Dalwadi, J. Schetz, 2017, Molecular Pharmacology.

A Reevaluation of the Structure in the Pore Region of Voltage-Activated Cation Channels.

J. Schetz, P. Anderson, 1993, The Biological bulletin.

Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein in the rat.

J. Taylor, M. Chorev, T. Davis, 1995, The Journal of pharmacology and experimental therapeutics.